HKU Scholars Hub: Browsing DSpace

Browsing by Author Marcellin, P

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 8 to 20 of 20 < previous

	Title	Author(s)	Issue Date	Views
	Characterization of HBsAg decline in the Tenofovir disoproxil fumarate (TDF) and peginterferon alfa 2A (PEG) combination study for chronic hepatitis B (CHB) Proceeding/Conference:Hepatology International	Chan, HLY Kadayifci, A Papatheodoridis, G Yuen, MF Chien, RN Kwan, WCP Lin, L Dinh, P Martins, EB Charuworn, P Subramanian, GM Mchutchison, JG Petersen, J Shiffman, M Reesink, HW Lim, SG Lim, YS Marcellin, P	2015	119
	IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB) Proceeding/Conference:Hepatology	Lim, Y Chan, HLY Seto, WKW Ning, Q Agarwal, K Janssen, HL Pan, CQ Chuang, WL Izumi, N Fung, SK Shalimar,Brunetto, MR Flaherty, JF Mo, S Cheng, C Lin, L Gaggar, A Subramanian, M Marcellin, P Gane, EJ Hou, J Buti, M	2019	120
	In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy Proceeding/Conference:Journal of Hepatology	Marcellin, P Chan, HLY Lai, CL Clio, M Heathcote, I Moon, YM Chao, YC Myers, R Harb, G Brown, NA	2007	134
	The neglected hepatitis C virus genotypes 4, 5 and 6: An international consensus report Journal:Liver International	Antaki, N Craxi, A Kamal, S Moucari, R Van Der Merwe, S Haffar, S Gadano, A Zein, N Lai, CL Pawlotsky, J Heathcote, EJ Dusheiko, G Marcellin, P	2010	152
	Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B Journal:New England Journal of Medicine	Marcellin, P Lau, GK Bonino, F Farci, P Hadziyannis, S Jin, R Lu, ZM Piratvisuth, T Germanidis, G Yurdaydin, C Diago, M Gurel, S Lai, MY Button, P Pluck, N	2004	147
	Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B Journal:New England Journal of Medicine	Lau, GK Piratvisuth, T Luo, KX Marcellin, P Thongsawat, S Cooksley, G Gane, E Fried, MW Chow, WC Paik, SW Chang, WY Berg, T Flisiak, R McCloud, P Pluck, N	2005	136
	Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B	Bonino, F Marcellin, P Lau, GKK Hadziyannis, S Jin, R Piratvisuth, T Germanidis, G Yurdaydin, C Diago, M Gurel, S Lai, MY Brunetto, MR Farci, P Popescu, M McCloud, P	2007	175
	A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 results Proceeding/Conference:Hepatology	Bzowej, N Chan, HLY Lai, CL Cho, M Moon, YM Chao, YC Heathcote, EJ Myers, R Minuk, G Marcellin, P Jeffers, L Sievert, W Kaiser, R Harb, G Chao, GC Brown, NA	2006	109
	A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Results of the Primary Week 24 Analysis Proceeding/Conference:Gastroenterology	Heathcote, EJ Chan, HL Cho, M Lai, CL Moon, YM Chao, YC Myers, R Minuk, G Marcellin, P Jeffers, L Sievert, W Kaiser, R Chao, G Brown, N	2006	120
	A randomized trial of telbivudine (LDT) vs. adefovir for HBeAg-positive chronic hepatitis B: Results of the primary week 24 analysis Proceeding/Conference:Journal of Hepatology	Chan, HLY Lai, CL Cho, M Heathcote, J Moon, Y-M Chao, Y-C Myers, R Minuk, G Marcellin, P Jeffers, L Sievert, W Kaiser, R Chao, G Brown, N	2006	132
	Responses to peginterferon alfa-2a (40KD) (PEGASYS) treatment are durable in Asian Patients with HBeAg-Negative CHB: 12 month Follow-Up Data from a large Randomised Study Proceeding/Conference:Journal of Gastroenterology and Hepatology	Marcellin, P Lau, GKK Piratvisuth, T Jin, R Lu, ZM Lai, MY Thongsawat, S Ramakrishnan, B Popescu, M	2006	39
	Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial Journal:The Lancet Gastroenterology & Hepatology	Buti, M Gane, E Seto, WKW Chan, HL Chuang, WL Stepanova, T Hui, AJ Lim, YS Mehta, R Janssen, H Acharya, SK Flaherty, J Massetto, B Cathcart, AL Kim, K Gaggar, A Subramanian, GM McHutchison, J Pan, C Brunetto, M Izumi, N Marcellin, P	2016	90
	Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial Journal:Annals of Internal Medicine	Chan, HLY Heathcote, EJ Marcellin, P Lai, CL Cho, M Moon, YM Chao, YC Myers, RP Minuk, GY Jeffers, L Sievert, W Bzowej, N Harb, G Kaiser, R Qiao, XJ Brown, NA Crawford, D Lim, SG Chutaputti, A Poynard, T	2007	97

Showing results 8 to 20 of 20 < previous